Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • The EMBO Journal (Home)
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Latest Online
  • Current Issue
  • Archive
  • Subject Collections
  • Review Series & Focuses

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Bibliometrics
  • Referee Guidelines
  • Open Access Charges

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Recommend to Librarian
  • Customer Service
  • Home
  • The EMBO Journal: 32 (5)

Source Data

Transparent Process

Article

hCAF1/CNOT7 regulates interferon signalling by targeting STAT1

Clément Chapat, Chloé Kolytcheff, Muriel Le Romancer, Didier Auboeuf, Pierre De La Grange, Kamel Chettab, Stéphanie Sentis, Laura Corbo
DOI 10.1038/emboj.2013.11 | Published online 05.02.2013
The EMBO Journal (2013) 32, 688-700
Clément Chapat
Université Lyon 1, Lyon, France Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France Equipe Labellisée « La Ligue », Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chloé Kolytcheff
Université Lyon 1, Lyon, France Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France Equipe Labellisée « La Ligue », Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muriel Le Romancer
Université Lyon 1, Lyon, France Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France Equipe Labellisée « La Ligue », Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Auboeuf
Université Lyon 1, Lyon, France Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre De La Grange
GenoSplice Technology, IUH, Centre Hayem, Saint‐Louis Hospital‐1, Paris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamel Chettab
Université Lyon 1, Lyon, France Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France Equipe Labellisée « La Ligue », Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphanie Sentis
Université Lyon 1, Lyon, France Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France Equipe Labellisée « La Ligue », Lyon, France Faculté de Pharmacie de Lyon, ISPB, Université Lyon 1, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Corbo
Université Lyon 1, Lyon, France Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France Equipe Labellisée « La Ligue », Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Clément Chapat1,2,3,†,
  2. Chloé Kolytcheff1,2,3,†,
  3. Muriel Le Romancer1,2,3,
  4. Didier Auboeuf1,2,
  5. Pierre De La Grange4,
  6. Kamel Chettab1,2,3,
  7. Stéphanie Sentis1,2,3,5 and
  8. Laura Corbo*,1,2,3
  1. 1 Université Lyon 1, Lyon, France
  2. 2 Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France
  3. 3 Equipe Labellisée « La Ligue », Lyon, France
  4. 4 GenoSplice Technology, IUH, Centre Hayem, Saint‐Louis Hospital‐1, Paris
  5. 5 Faculté de Pharmacie de Lyon, ISPB, Université Lyon 1, Lyon, France
  1. ↵*Corresponding author. Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Université Lyon 1, Centre Léon Bérard, 28 rue Laennec, 69373 Lyon Cedex 08, France. Tel.:+33 4 78 78 26 91; Fax:+33 4 78 78 27 20; E-mail: laura.corbo{at}lyon.unicancer.fr
  1. ↵† These authors contributed equally to this work.

View Full Text
  • Article
  • Figures & Data
  • Transparent Process
Loading

Article Information

vol. 32 no. 5 688-700
DOI 
https://doi.org/10.1038/emboj.2013.11
PubMed 
23386060
Print ISSN 
0261-4189
Online ISSN 
1460-2075
History 
  • Published online February 5, 2013.
  • Published in print March 6, 2013.
Review Process File

Author Information

  1. Clément Chapat1,2,3,†,
  2. Chloé Kolytcheff1,2,3,†,
  3. Muriel Le Romancer1,2,3,
  4. Didier Auboeuf1,2,
  5. Pierre De La Grange4,
  6. Kamel Chettab1,2,3,
  7. Stéphanie Sentis1,2,3,5 and
  8. Laura Corbo*,1,2,3
  1. 1 Université Lyon 1, Lyon, France
  2. 2 Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France
  3. 3 Equipe Labellisée « La Ligue », Lyon, France
  4. 4 GenoSplice Technology, IUH, Centre Hayem, Saint‐Louis Hospital‐1, Paris
  5. 5 Faculté de Pharmacie de Lyon, ISPB, Université Lyon 1, Lyon, France
  1. ↵*Corresponding author. Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Université Lyon 1, Centre Léon Bérard, 28 rue Laennec, 69373 Lyon Cedex 08, France. Tel.:+33 4 78 78 26 91; Fax:+33 4 78 78 27 20; E-mail: laura.corbo{at}lyon.unicancer.fr
  1. ↵† These authors contributed equally to this work.

View Full Text
Previous Article in this IssueNext Article in this Issue
Back to top

  • PDF
  • Share
  • Export
  • Print
Loading

PDF

Review Process

In this Issue
Volume 32, Issue 5
06 March 2013
The EMBO Journal: 32 (5)
About the cover
Alert me when this article is cited
Alert me if a correction is posted

Article

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and methods
    • Conflict of Interest
    • Supplementary Information
    • Acknowledgements
    • References
  • Figures & Data
  • Transparent Process

Related Content

More Article

  • Large cargo transport by nuclear pores: implications for the spatial organization of FG‐nucleoporins
    Li‐Chun Tu, Guo Fu, Anton Zilman, Siegfried M Musser
    The EMBO Journal 32: 3220-3230
  • SERCA mutant E309Q binds two Ca2+ ions but adopts a catalytically incompetent conformation
    Johannes D Clausen, Maike Bublitz, Bertrand Arnou, Cédric Montigny, Christine Jaxel, Jesper Vuust Møller, Poul Nissen, Jens Peter Andersen, Marc le Maire
    The EMBO Journal 32: 3231-3243
  • Cohesin‐mediated interactions organize chromosomal domain architecture
    Sevil Sofueva, Eitan Yaffe, Wen‐Ching Chan, Dimitra Georgopoulou, Matteo Vietri Rudan, Hegias Mira‐Bontenbal, Steven M Pollard, Gary P Schroth, Amos Tanay, Suzana Hadjur
    The EMBO Journal 32: 3119-3129
More Article

Related Articles

Cited By...

Request Permissions

Subject Areas

  • Immunology
  • RNA Biology
  • Signal Transduction

Journal

  • Latest Online
  • Current Issue
  • Archive
  • Bibliometrics
  • E-Mail Editorial Office
  • Privacy Policy

Authors & Referees

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Recommend to Librarian
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1460-2075

Copyright© 2019 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.